Esmer C, Salazar MA, Rentería PE, Bravo OA

Language: Spanish
References: 27
Page: 314-319
PDF size: 151.21 Kb.

ABSTRACT

Background. Ataxia with vitamin E deficiency is a disorder caused by mutations in the TTPA gene. Common symptoms include ataxia, areflexia, head titubation, loss of proprioception, Babinsky sign, dysdiadochokinesia, retinitis pigmentosa and cardiomyopathy.
Case report. The patient was the first child of consanguineous parents. She presented at 10 years of age due to bilateral lower limb pain and numbness and difficulty in speech, writing and chewing. Physical examination showed dysarthria, diminished distal strength, hyperreflexia, positive Babinsky sign, decreased proprioception, pes cavus, dysmetria, dysdiadochokinesia and positive Romberg sign. Genetic screening for the Friedreich’s ataxia gene resulted negative, α-tocopherol levels were low and TTPA gene sequencing detected the homozygous mutation c.205-1G ›C in intron 1. Treatment was initiated with vitamin E, showing improvement of symptoms.
Conclusions. The presence of Friedreich’s ataxia-like phenotype suggests the need to perform tests of plasma levels of α-tocopherol and the confirmatory genetic test. Treatment with vitamin E decreases symptoms in both affected and presymptomatic individuals. Few patients have been described in America, and our case showed a homozygous mutation outside of high-prevalence areas. Clinical findings of this patient and a previous case would indicate that the c.205-1G›C mutation is associated with severe symptoms.

REFERENCES

1. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922;56:650-651.

2. Zingg JM. Vitamin E: an overview of major research directions. Mol Aspects Med 2007;28:400-422.

3. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, et al. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990;85:397-407.

4. Harding AE, Matthews S, Jones S, Ellis CJ, Booth IW, Muller DP. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med 1985;313:32-35.

5. Willison HJ, Muller DP, Matthews S, Jones S, Kriss A, Stead RJ, et al. A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. J Neurol Neurosurg Psychiatry 1985;48:1097-1102.

6. Harding AE, Muller DP, Thomas PK, Willison HJ. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol 1982;12:419-424.

7. Howard L, Ovesen L, Satya-Murti S, Chu R. Reversible neurological symptoms caused by vitamin E deficiency in a patient with short bowel syndrome. Am J Clin Nutr 1982;36:1243-1249.

8. Burck U, Goebel HH, Kuhlendahl HD, Meier C, Goebel KM. Neuromyopathy and vitamin E deficency in man. Neuropaediatrics 1981;12:267-278.

9. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 1995;9:141-145.

10. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, et al. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet 1993;5:195-200.

11. Di Donato I, Bianchi S, Federico A. Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci 2010;31:511-515.

12. Benomar A, Yahyaoui M, Meggouh F, Bouhouche A, Boutchich M, Bouslam N, et al. Clinical comparison between AVED patients with 744delA mutation and Friedreich ataxia with GAA expansion in 15 Moroccan families. J Neurol Sci 2002;198:25-29.

13. Cavalier L, Ouahchi K, Kayden HJ, Di Donato S, Reutenauer L, Mandel JL, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998;62: 301-310.

14. Zortea M, Armani M, Pastorello E, Nunez GF, Lombardi S, Tonello S, et al. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology 2004;23: 275-280.

15. Mariotti C, Gellera C, Rimoldi M, Mineri R, Uziel G, Zorzi G, et al. Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci 2004;25: 130-137.

16. Koht J, Bjørnarå KA, Jørum E, Tallaksen CM. Ataxia with vitamin E deficiency in southeast Norway, case report. Acta Neurol Scand 2009;189(suppl):42-45.

17. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983;1:1151-1155.

18. Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med 2013;28.

19. Schuelke M. Ataxia with vitamin E deficiency. En: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, eds. GeneReviews [Internet]. Seattle (WA): University of Washington; 2005. pp. 1993-2013.

20. Gabsi S, Gouider-Khouja N, Belal S, Fki M, Kefi M, Turki I, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol 2001;8:477-481.

21. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007;6:245-257.

22. Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, Kayden HJ, et al. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J 1995;306:437-443.

23. Zingg JM. Modulation of signal transduction by vitamin E. Mol Aspects Med 2007;28:481-506.

24. Zingg JM, Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem 2004;11:1113-1133.

25. Amiel J, Maziere JC, Beucler I, Koenig M, Reutenauer L, Loux N, et al. Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. J Inherit Metab Dis 1995;18:333-340

26. Muller DP. Vitamin E and neurological function. Mol Nutr Food Res 2010;54:710-718.

27. Ricciarelli R, Argellati F, Pronzato MA, Domenicotti C. Vitamin E and neurodegenerative diseases. Mol Aspects Med 2007;28:591-606.